Drug transporters and their role in multidrug resistance of neoplastic cells

General Physiology and Biophysics

Volumn 20, Issue 3, 2001, Pages 215-237

  Kvackajova Kisuck J ^a   Barancik M ^a   Breier, A ^a  

^a INSTITUTE OF MOLECULAR PHYSIOLOGY AND GENETICS   (Slovakia)

Author keywords

ABC transporters; MRP protein; Multidrug resistance; P glycoprotein

Indexed keywords

ABC TRANSPORTER; ADENOSINE TRIPHOSPHATASE; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; BEPRIDIL; COLCHICINE; DACTINOMYCIN; DAUNORUBICIN; DOXORUBICIN; DRUG CARRIER; EPIPODOPHYLLOTOXIN DERIVATIVE; EPIRUBICIN; ETOPOSIDE; GENE PRODUCT; GLYCOPROTEIN P; GRAMICIDIN D; MITOMYCIN C; MULTIDRUG RESISTANCE PROTEIN; NICARDIPINE; NIFEDIPINE; NIGULDIPINE; NITRENDIPINE; PACLITAXEL; TRIFLUOPERAZINE; UNINDEXED DRUG; VALINOMYCIN; VERAPAMIL; VINBLASTINE; VINCA ALKALOID; VINCRISTINE;

BINDING COMPETITION; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG PROTEIN BINDING; DRUG TRANSPORT; GENE FUNCTION; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN TISSUE; MEMBRANE TRANSPORT; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; RAT; REVIEW; TISSUE DISTRIBUTION; TUMOR CELL;

VINCA;

EID: 0034767050     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (149)

1. Characterization of the human ABC superfamily: Isolation and mapping of 21 new genes using the expressed sequence tags database
2. Covalent inhibitors of P-glycoprotein ATPase activity
3. Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance
4. Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain
5. Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome
6. 2+-entry blockers, neuroleptics and local anaesthetics on P-glycoprotein-mediated vincristine resistance of L1210/VCR mouse leukaemia cell line
7. Effect of phorbol myristate acetate (PMA) on P-glycoprotein mediated vincristine resistance of L1210 cells
8. Differential expression of regulatory proteins in L1210/VCR cells with multidrug resistance mediated by P-glycoprotein
9. SB20380, a specific inhibitor of P38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance
10. Multidrug resistance protein-mediated transport of chlorambucil and melphalan conjugated to glutathione
11. Overexpression and purification of the carboxyl-terminal nucleotide-binding domain from mouse P-glycoprotein. Strategic location of a tryptophan residue
12. Photoaffinity substrates for P-glycoprotein
13. Altered DNA topoisomerase II in multidrug resistance
14. Pleiotropic phenotype of colchicine-resistant CHO cells: Cross-resistance and collateral sensitivity
15. Novel multidrug resistance reversal agents
16. Restoration of TNF-alpha-induced ceramide generation and apoptosis in resistant human leukemia KG1a cells by the P-glycoprotein blocker PSC833
17. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: Cross-resistance, radioautographic, and cytogenetic studies
18. Membrane-mediated drug resistance and phenotypic reversion to normal growth behavior of Chinese hamster cells
19. Cytokine production by subsets of CD4 memory T cells differing in P-glycoprotein expression: Effects of aging
20. Glutatione S-Transferase does not play a role in multidrug resistance of L1210/VCR cell line
21. Heterogeneity in P-glycoprotein (multidrug resistance) activity among murine peripheral T cells: Correlation with surface phenotype and effector function
22. Protein kinase C phosphorylation disengages human and mouse-1a P-glycoproteins from influencing the rate of activation of swelling-activated chloride currents
23. Phosphatidylcholine and phosphatidylethanolamine behave as substrates of the human MDR1 P-glycoprotein
24. A comparison of the phenomenology and genetics of multidrug resistance in cancer cells and quinoline resistance in Plasmodium falciparum
25. Effect of pentoxifylline on P-glycoprotein mediated vincristine resistance of L1210 mouse leukemic cell line
26. Cytotoxic activity of several unrelated drugs on L1210 mouse leukemic cell sublines P-glycoprotein (PGP) mediated multidrug resistance (MDR) phenotype. A QSAR study
27. Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias
28. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats
29. Heavy metal resistance: New role for P-glycoproteins in Leishmania
30. Action of calcium antagonists on multidrug resistance
31. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma
32. In situ biochemical demonstration that P-glycoprotein is a drug efflux pump with broad specificity
33. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug resistant human cells
34. The MDR superfamily of genes and its biological implications
35. Multidrug resistance-associated protein: Sequence correction
36. Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP
37. Overexpression of a transporter gene in a multidrug resistant human lung cancer cell line
38. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues
39. Recombinant N-terminal nucleotide-binding domain from mouse P-glycoprotein. Overexpression, purification, and role of cysteine 430
40. Role of multidrug resistance P-glycoproteins in cholesterol esterification
41. Function, evolution and structure of multidrug resistance protein (MRP)
42. The effect of pentoxifylline on P-glycoprotein mediated multidrug resistance of L1210/VCR cells
43. The biochemistry of P-glycoprotein-mediated multidrug resistance
44. Transport of glutathione prostaglandin A conjugates by the multidrug resistance protein 1
45. Identification of novel drug resistance-associated proteins by a panel of rat monoclonal antibodies
46. Modulators of multidrug resistance. Preclinical studies
47. The multidrug transporter, a double-edged sword
48. Biochemistry of multidrug resistance mediated by the multidrug transporter
49. Genetic analysis of the multidrug transporter
50. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs
51. Isolation and expression of a complementary DNA that confers multidrug resistance
52. Lipophilic cations: A group of model substrates for the multidrug-resistance transporter
53. Gene families: The taxonomy of protein paralogs and chimeras
54. ABC transporters: From microorganisms to man
55. Membrane topology of the multidrug resistance protein (MRP)
56. Influence of P-glycoprotein on the transport and metabolism of indinavir in Caco-2 cells expressing cytochrome P-450 3A4
57. Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2
58. Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport
59. A subfamily of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels
60. Coordinated induction of MRP/GS-X pump and gamma-glutamylcysteine synthetase by heavy metals in human leukemia cells
61. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein
62. Transport of glutathione, glucuronate and sulfate conjugates by the MRP gene-encoded conjugate export pump
63. ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2
64. P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death
65. Multiple physiological functions for multidrug transporter P-glycoprotein?
66. A surface glycoprotein modulating drug permeability in Chinese ovary cell mutants
67. Transmembrane organization of mouse P-glycoprotein determined by epitope insertion and immunofluorescence
68. Expression of an ATP-binding cassette transporter-encoding gene (YOR1) is required for oligomycin resistance in Saccharomyces cerevisiae
69. Assembly and function of the two ABC transporter protein encoded in the human major histocompatibility complex
70. The function of the multidrug resistance proteins (MRP and cMRP) in drug conjugate transport and hepatobiliary excretion
71. Transport function and substrate specificity of multidrug resistance protein
72. Export pumps for anionic conjugates encoded by MRP genes
73. Mode of action of calcium antagonists which alter anthracycline resistance
74. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors
75. P-glycoprotein expression and function in circulating blood cells from normal volunteers
76. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines
77. Conjugate export pumps of the multidrug resistance protein (MRP) family: Localization, substrate specificity, and MRP2-mediated drug resistance
78. Cholesterol homeostasis. Modulation by amphiphiles
79. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter
80. Effect of ABC transporters on HIV-1 infection: Inhibition of virus production by the MDR1 transporter
81. Characterization of the ATP-dependent leukotriene C4 export carrier in mastocytoma cells
82. ATP-dependent glutathione disulphide transport mediated by the MRP gene-encoded conjugate export pump
83. Multidrug resistance: Molecular mechanisms and clinical relevance
84. 4 and chemotherapeutic agents in membrane vesicles
85. 1 and its glutathione conjugates by the product of the multidrug resistance protein (MRP) gene
86. Characterization of vincristine transport by the M(r) 190,000 kDa multidrug resistance protein (MRP): Evidence for cotransport with reduced glutathione
87. Functional consequences of glycine mutations in the predicted cytoplasmic loops of P-glucoprotein
88. Reconstitution of drug-stimulated ATP-ase activity following co-expression of each half of human P-glycoprotein as separate polypeptides
89. P-glycoprotein. Associations between domains and between domains and molecular chaperones
90. Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/CED-3 proteases)
91. P-170 glycoprotein (P-170) is involved in the impairment of natural killer cell-mediated cytotoxicity in HIV+ patients
92. Multidrug resistance (MDR1) P-glycoprotein enhances esterification of plasma membrane cholesterol
93. Stage-specific distribution of P-glycoprotein in first-trimester and full-term human placenta
94. Glutathione S-transferases and drug resistance
95. Multidrug resistance protein and glutathione S-transferase P1-1 act in synergy to confer protection from 4-nitroquinoline 1-oxide toxicity
96. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport
97. Role of multidrug resistance protein (MRP) in glutathione S-conjugate transport in mammalian cells
98. Glutathione and related enzymes in multidrug resistance
99. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents
100. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene
101. A mutation in a human canalicular multispecific organic anion transporter gene causes Dubin-Johnson syndrome
102. Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitor
103. Reversal of acquired resistance to doxorubicin in P188 murine leukemia cells by tamoxifen and other triparanolanalogues
104. A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels
105. Choroid plexus epithelial expression of MDR1 P-glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier
106. Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins
107. BCL-2: Prevention of apoptosis as a mechanism of drug resistance
108. ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1
109. Prognostics implicatons of imunodetection of P glycoprotein in Eving's sarcoma
110. Human MDR1 protein overexpression delays the apoptotic cascade in Chinese hamster ovary fibroblasts
111. Phosphatidylcholine translocase: A physiological role for the mdr2 gene
112. Cytogenetics and P-glycoprotein are independent predictors of treatment outcome in acute myeloid leukemia
113. P-glycoprotein-mediated Hoechst 33342 transport out of the lipid bilayer
114. Cloning, overexpression, purification, and characterization of the carboxyl-terminal nucleotide binding domain of P-glycoprotein
115. Linear and cyclic peptides as substrates and modulators of P-glycoprotein: Peptide binding and effects on drug transport and accumulation
116. Cell biological mechanisms of multidrug resistance in tumors
117. The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis
118. Human immunodeficiency virus protease inhibitors serve as substrates for multidrug transporter proteins MDR1 and MRP1 but retain antiviral efficacy in cell lines expressing these transporters
119. Pharmacological characterization of the murine and human orthologs of multidrug-resistance protein in transfected human embryonic kidney cells
120. A yeast metal resistance protein similar to human cystic fibrosis transmembrane conductance regulator (CFTR) and multidrug resistance-associated protein
121. Overcoming of P-glycoprotein mediated vincristine resistance of L1210/VCR mouse leukemic cells could be induced by pentoxifylline but not by theophylline and caffeine
122. Anti-cancer drugs and glutathione stimulate vanadate-induced trapping of nucleotide in multidrug resistance-associated protein (MRP)
123. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues
124. Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P-170: Evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein
125. Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter, P-glycoprotein
126. Increased accumulation of vincristine and adriamycin in drug resistance P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors
127. Differential effect of verapamil and flunarizine on cardiac L-type and T-type Ca channels
128. Modification of cytotoxic drug resistance by non-immunosuppressive cyclosporins
129. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone
130. Characterization of the ATPase activity of purified Chinese hamster P-glycoprotein
131. Both P-glycoprotein nucleotide-binding sites are catalytically active
132. The multidrug resistance P-glycoprotein modulates cell regulatory volume decrease
133. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine
134. Multidrug resistance gene (P-glycoprotein) expression in the human fetus
135. Phosphorylation of P-glycoprotein by PAK and PKC modulates swelling-activated CI-currents
136. Expression of P-glycoprotein and in vitro or in vivo resistance to doxorubicin and cysplatin in breast and ovarian cancer
137. Resistance to cytostatic drugs at the cellular level
138. Reversal of MRP-mediated doxorubicin resistance with quinoline-based drugs
139. Genomic and cDNA sequence tags of the hyperthermophilic Archaeon Pyrobaculum aerophilum
140. Distantly related sequences in α- and β-subunits of ATP synthase, myosin, kinases and other Atp-requiring enzymes and a common nucleotide binding fold
141. Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (Pgp) in human cultured cells
142. Cellular drug efflux and reversal therapy of cancer
143. An insect model for assessing arsenic toxicity: Arsenic elevated glutathione content in the Musca domestica and Trichoplusia ni
144. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines
145. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump
146. Transport of the glutathione conjugate of ethacrynic acid by the human multidrug resistance protein MRP
147. Resistance to paclitaxel mediated by P-glycoprotein can be modulated by changes in the schedule of administration
148. Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus